Related Experiment Videos

Therapeutic management strategies for type 2 diabetes

C Ramesh1, V Gopal, K Sembulingam

  • 1College of Pharmacy, Mother Theresa Institute of Health Sciences, Gorimedu, Pondicherry-605006, India.

Current Diabetes Reviews
|January 29, 2008
PubMed

Insights

Diabetes mellitus, affecting millions globally, presents serious complications. This study focuses on key strategies to manage type 2 diabetes and prevent its associated health issues.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Public Health

Background:

  • Diabetes mellitus (type 1 and type 2) is a global health concern with severe macrovascular and microvascular complications.
  • Complications include retinopathy, cardiovascular diseases, and nephropathy, significantly impacting patient quality of life.
  • Current treatments focus on management and complication control, lacking definitive curative agents.

Purpose of the Study:

  • To outline principle management strategies for type 2 diabetes.
  • To provide insights into preventing or delaying the onset of diabetes.
  • To focus on controlling diabetes-related complications.

Main Methods:

  • Literature review of current diabetes management principles.
  • Analysis of established and emerging strategies for type 2 diabetes.
  • Synthesis of evidence-based approaches for complication prevention and control.

Main Results:

  • Identified key lifestyle modifications crucial for type 2 diabetes management.
  • Highlighted the importance of pharmacological interventions in controlling blood glucose levels.
  • Emphasized the role of regular monitoring in mitigating long-term complications.

Conclusions:

  • Effective management of type 2 diabetes requires a multi-faceted approach.
  • Preventative strategies and diligent complication control are paramount.
  • This work provides a framework for optimizing type 2 diabetes care.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...